SS
CSBR icon

SBI Securities’s Champions Oncology CSBR Stock Holding History

SBI Securities’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25 Hold
4
– – ﹤0.01% 3806
2026
Q1 		$23 Hold
4
– – ﹤0.01% 3737
2025
Q4 		$28 Sell
4
-12
-75% -$80 ﹤0.01% 3711
2025
Q3 		$104 Sell
16
-10
-38% -$70 ﹤0.01% 3509
2025
Q2 		$192 Buy
26
+10
+63% +$71 ﹤0.01% 3321
2025
Q1 		$139 Buy
16
+12
+300% +$122 ﹤0.01% 3338
2024
Q4 		$34 Buy
+4
New +$20 ﹤0.01% 3713

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $368M AUM 28.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SBI Securities's CSBR Position: Q2 2026 in Review

SBI Securities held its Champions Oncology (CSBR) position steady in Q2 2026 at 4 shares worth $25. The position accounts for ﹤0.01% of the portfolio, ranked #3806.

SBI Securities first reported a position in CSBR in Q4 2024 and has held it in 7 quarters since. The position peaked at $192 in Q2 2025. 28 funds tracked by Wall St. Rank hold CSBR as of Q2 2026.

  • SBI Securities held 4 shares of Champions Oncology worth $25 as of Q2 2026.
  • SBI Securities left its Champions Oncology share count unchanged in Q2 2026.
  • Champions Oncology made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3806 holding.
  • SBI Securities first reported a position in Champions Oncology in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Champions Oncology position peaked at $192 in Q2 2025.
  • 28 funds tracked by Wall St. Rank held Champions Oncology as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.